265 Results

People

  1. Zelenetz
    Zelenetz
  2. Hamlin
    Hamlin
  3. Noy
    Noy
  4. Horwitz
    Horwitz
  5. Moskowitz
    Moskowitz
  6. Palomba
    Palomba
  7. Moskowitz
    Moskowitz
  8. Matasar
    Matasar
  9. Kumar
    Kumar
  10. Portlock
    Portlock

Groups

  1. Center for Hematologic Malignancies (265)
  2. Department of Medicine (265)
  3. Hematologic Malignancies, Division of (265)
  4. Lymphoma (265)
  5. Population Sciences Research Program (134)
  6. Survivorship Research (134)
  7. Epidemiology and Biostatistics (85)
  8. Biostatistics Service (69)
  9. Executive Committee, Center for Hematologic Malignancies (65)
  10. Radiology, Department of (65)
  1. "Paul Hamlin"
Formats
  1. Meeting Abstract (165)
  2. Journal Article (95)
  3. Research Letter (5)
Groups
  1. Center for Hematologic Malignancies (265)
  2. Department of Medicine (265)
  3. Hematologic Malignancies, Division of (265)
  4. Lymphoma (265)
  5. Population Sciences Research Program (134)
  6. Survivorship Research (134)

More Groups

People
  1. Paul Hamlin (265)
  2. Andrew Zelenetz (164)
  3. Ariela Noy (123)
  4. Steven Horwitz (121)
  5. David Straus (117)
  6. Craig Moskowitz (112)

More People

Years
  1. 2024 (2)
  2. 2023 (21)
  3. 2022 (12)
  4. 2021 (17)
  5. 2020 (13)
  6. 2019 (23)

More Years

Publications
  1. Blood (108)
  2. Journal of Clinical Oncology (37)
  3. Hematological Oncology (15)
  4. Annals of Oncology (12)
  5. British Journal of Haematology (11)
  6. Blood Advances (8)

More Publications

Publishers
  1. American Society of Hematology (116)
  2. American Society of Clinical Oncology (39)
  3. Wiley Blackwell (19)
  4. Elsevier Inc. (14)
  5. Oxford University Press (13)
  6. John Wiley & Sons (11)

More Publishers

Results (265)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Identification of actionable genomic alterations across different lymphoma histologies using a comprehensive next generation genomic sequencing clinical assay
    Meeting Abstract

    Batlevi, C.; Moskowitz, C. H.; Zelenetz, A. D.; Horwitz, S. M.; Palomba, L.; Gerecitano, J. F.; Copeland, A. R.; Hamlin, P.; Matasar, M. J.; Sauter, C. S.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Phase I dose-escalation study of SGN-75 in patients with CD70-positive relapsed/refractory non-Hodgkin lymphoma or metastatic renal cell carcinoma
    Journal Article

    Tannir, N. M.; Forero-Torres, A.; Ramchandren, R.; Pal, S. K.; Ansell, S. M.; Infante, J. R.; de Vos, S.; Hamlin, P. A.; Kim, S. K.; Whiting, N. C.; more...
    Investigational New Drugs (2014)

    Fulltext@MSK | Save
  • Treatment patterns and comparative effectiveness in elderly diffuse large B-cell lymphoma patients: A surveillance, epidemiology, and end results-medicare analysis
    Journal Article

    Hamlin, P. A.; Satram-Hoang, S.; Reyes, C.; Hoang, K. Q.; Guduru, S. R.; Skettino, S.
    The Oncologist (2014)

    Fulltext@MSK | Save
  • Favorable outcomes in elderly patients undergoing high-dose therapy and autologous stem cell transplantation for non-Hodgkin lymphoma
    Journal Article

    Dahi, P. B.; Tamari, R.; Devlin, S. M.; Maloy, M.; Bhatt, V.; Scordo, M.; Goldberg, J.; Zelenetz, A. D.; Hamlin, P. A.; Matasar, M. J.; more...
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • Evolving treatment paradigms for primary mediastinal diffuse large B-cell lymphoma
    Journal Article

    Hamlin, P. A.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Pancreatitis in patients treated with brentuximab vedotin: A previously unrecognized serious adverse event
    Journal Article

    Gandhi, M. D.; Evens, A. M.; Fenske, T. S.; Hamlin, P.; Coiffier, B.; Engert, A.; Moskowitz, A. J.; Ghosh, N.; Petrich, A. M.; Lomasney, J.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • SGN-75 in the treatment of patients with CD70-positive malignancies including metastatic renal cell carcinoma
    Meeting Abstract

    Thompson, J. A.; Forero, A.; Heath, E. I.; Pal, S. K.; Ansell, S. M.; Infante, J. R.; De Vos, S.; Hamlin, P. A.; Whiting, N. C.; Zhao, B.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Infectious disease associations in advanced stage, indolent lymphoma (follicular, FL, and nonfollicular, nFL): A prospective trial of antibiotic therapy
    Meeting Abstract

    Portlock, C. S.; Hamlin, P. A.; Gerecitano, J. F.; Noy, A.; Palomba, M. L.; Walkley, J.; Corcoran, S.; Papanicolaou, G. A.; Markowitz, A.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Pancreatitis in patients treated with brentuximab vedotin: A previously unrecognized serious adverse event
    Meeting Abstract

    Gandhi, M.; Evens, A. M.; Fenske, T. S.; Hamlin, P.; Coiffier, B.; Engert, A.; Moskowitz, A. J.; Ghosh, N.; Petrich, A. M.; Lomasney, J.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • FDG-PET adapted sequential therapy with brentuximab vedotin and augmented ICE followed by autologous stem cell transplant for relapsed and refractory Hodgkin lymphoma
    Meeting Abstract

    Moskowitz, A.; Schoder, H.; Gerecitano, J. F.; Hamlin, P.; Horwitz, S. M.; Matasar, M. J.; Keskinyan, V. S.; McCall, S.; Noy, A.; Palomba, M. L.; more...
    Blood (2013)

    Fulltext@MSK | Save